Andritz AG (ADRZY)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	6,832	5,031	6,166	5,677	5,123	4,579
Market Cap Growth	17.56%	-18.41%	8.62%	10.82%	11.88%	5.22%
Enterprise Value	6,346	4,337	5,646	4,981	4,997	4,658
Last Close Price	14.19	9.76	12.10	10.54	9.31	7.96
PE Ratio	12.54	9.79	10.93	12.97	13.84	18.07
PS Ratio	0.73	0.58	0.64	0.70	0.70	0.56
PB Ratio	2.68	2.13	2.59	2.90	2.87	2.98
P/TBV Ratio	5.17	3.81	4.62	5.89	7.44	13.67
P/FCF Ratio	19.20	10.63	27.32	9.56	10.74	10.02
P/OCF Ratio	11.71	7.63	14.88	7.47	8.51	8.11
EV/Sales Ratio	0.69	0.50	0.59	0.62	0.68	0.57
EV/EBITDA Ratio	7.00	5.34	6.20	6.26	6.87	8.53
EV/EBIT Ratio	9.82	6.86	7.81	8.33	9.62	14.65
EV/FCF Ratio	17.84	9.17	25.02	8.39	10.48	10.19
Debt / Equity Ratio	0.34	0.36	0.53	0.70	0.87	1.22
Debt / EBITDA Ratio	0.94	0.97	1.31	1.62	2.00	3.12
Debt / FCF Ratio	2.44	1.78	5.58	2.32	3.26	4.10
Asset Turnover	1.00	1.00	1.02	0.93	0.88	0.94
Inventory Turnover	3.31	3.73	4.17	3.98	4.11	4.70
Quick Ratio	0.69	0.86	0.88	0.91	0.96	1.01
Current Ratio	1.11	1.17	1.18	1.18	1.22	1.26
Return on Equity (ROE)	21.50%	22.38%	25.26%	23.67%	22.79%	16.46%
Return on Assets (ROA)	4.40%	4.58%	4.81%	4.33%	3.88%	2.27%
Return on Capital (ROIC)	11.96%	11.95%	12.73%	11.54%	9.97%	5.78%
Return on Capital Employed (ROCE)	17.50%	17.60%	18.70%	16.10%	13.10%	7.60%
Earnings Yield	7.97%	10.22%	9.15%	7.71%	7.23%	5.53%
FCF Yield	5.21%	9.40%	3.66%	10.46%	9.31%	9.98%
Dividend Yield	2.44%	27.58%	22.83%	21.30%	20.15%	15.36%
Payout Ratio	54.71%	50.05%	40.71%	39.84%	30.48%	24.00%
Buyback Yield / Dilution	1.28%	0.08%	-0.33%	0.34%	-0.05%	0.94%
Total Shareholder Return	3.72%	27.66%	22.50%	21.64%	20.10%	16.30%

Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.